Analyst firms · Needham · HIMS
Needham HIMS price target and rating history
Hims & Hers Health Inc. (HIMS) · Health Care
Needham rates Hims & Hers Health Inc. (HIMS) Buy with a $35 price target, as of its latest action on May 12, 2026. It has published 5 rating actions on HIMS since August 2024, including 1 upgrade and 1 downgrade. Across 5 firms with a HIMS price target in the last 12 months, the median target is $33. Needham's $35 is 6% above that.
- Current rating
- Buy
- Price target
- $35
- Median target, all firms
- $33
- Actions on HIMS
- 5
Needham price target on HIMS
Every Needham rating on HIMS
- May 12, 2026
- Mar 9, 2026
- Jun 23, 2025DowngradeNeedham downgrades to Hold from Buy
- Jun 4, 2025
- Aug 22, 2024
How other firms rate HIMS
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Needham | Buy | $35 | May 12, 2026 |
| Citigroup | Neutral | $24 | Mar 10, 2026 |
| BofA Securities | Neutral | $23 | Mar 10, 2026 |
| BTIG | Neutral | Feb 24, 2026 | |
| Evercore ISI | In-line | $33 | Jan 12, 2026 |
| Barclays | Overweight | $48 | Dec 9, 2025 |
Questions about Needham and HIMS
- What is Needham's price target for HIMS?
- Needham's latest stated price target for Hims & Hers Health Inc. (HIMS) is $35, from its action on May 12, 2026.
- What is Needham's rating on HIMS?
- Needham rates HIMS Buy, a bullish rating, as of May 12, 2026.
- When did Needham last change its view on HIMS?
- On May 12, 2026, Needham raises its price target to $35 from $30, keeps Buy.
- How does Needham's HIMS target compare with other analysts?
- Across 5 firms with a HIMS price target in the last 12 months, the median target is $33. Needham's $35 is 6% above that.
More HIMS rating histories
All Needham ratingsHIMS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.